Hendrik Sy
Hendrik Sy has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Andras Farkas
Optimum Dosing Strategies, Bloomingdale, NJ, USA
2 shared publications - Arsheena Yassin
Robert Wood Johnson University Hospital
2 shared publications - Christian Olivo-Freites
Ryan Health, Infectious Diseases, New York, New York
2 shared publications Christine Stavropoulos
Icahn School of Medicine at Mount Sinai St Luke’s and West Hospitals, New York, NY
2 shared publicationsAlbert I. Ko
Yale School of Public Health, Yale University
1 shared publication- Alvaro Jose Martinez-Valencia
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (11) , e0014855
Spatio-temporal clustering of dengue in Valle del Cauca, Colombia
Background: Dengue is endemic in Colombia's Valle del Cauca region. The precise timing and spatial scale of seasonal dengue transmission necessary for effective reactive interventions at the sub-municipal level across the 42 municipalities of Valle del Cauca remain unclear. This study aimed to identify spatio-temporal dengue clusters in Valle del Cauca. Methodology/Principal Findings: A retrospective observational study was conducted using individual laboratory-confirmed dengue cases, including residential geolocation and consultation dates, reported by healthcare providers to the Sistema Nacional de Vigilancia en Salud Pública (SIVIGILA) in 2022. Residence was utilized as the probable site of infection. Spatio-temporal clustering was analyzed using Kulldorff's space-time scan statistic to identify statistically significant dengue clusters. Results were mapped using R. As a second aim, the association between clinical and demographic characteristics and dengue hospitalization was evaluated. Of 3,964 dengue cases reported in Valle del Cauca in 2022, 2,232 (56%) were laboratory-confirmed. Of these, 1,973 occurred in the defined areas of the nine municipalities included in the spatio-temporal analysis of this study. We identified 28 clusters at the sub-municipal level, with radii of 0–0.98 km, lasting 1–6 months and containing 10–114 cases. Twenty-six clusters (92.9%) spanned both warm–dry and cool–wet seasons, and clusters accounted for 32.0% of spatially analyzed cases. 960 patients were hospitalized. Lower socioeconomic status (OR 1.30, 95% CI 1.07–1.57), enrollment in the state-subsidized insurance scheme (OR 1.74, 95% CI 1.41–2.15) compared with the contributory scheme, and age ≥ 70 years compared to ages 20–29 years (OR 2.47, 95% CI 1.51–4.04) were associated with higher odds of hospitalization. Conclusions/Significance: This study identified dengue clusters at the sub-municipal level with the potential to inform reactive dengue control interventions and demonstrated a disproportionate impact on socioeconomically disadvantaged populations and the elderly in Valle del Cauca, Colombia.
- 10 November 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (11) , e0014855
Open AccessSpatio-temporal clustering of dengue in Valle del Cauca, Colombia
Background: Dengue is endemic in Colombia's Valle del Cauca region. The precise timing and spatial scale of seasonal dengue transmission necessary for effective reactive interventions at the sub-municipal level across the 42 municipalities of Valle del Cauca remain unclear. This study aimed to identify spatio-temporal dengue clusters in Valle del Cauca. Methodology/Principal Findings: A retrospective observational study was conducted using individual laboratory-confirmed dengue cases, including residential geolocation and consultation dates, reported by healthcare providers to the Sistema Nacional de Vigilancia en Salud Pública (SIVIGILA) in 2022. Residence was utilized as the probable site of infection. Spatio-temporal clustering was analyzed using Kulldorff's space-time scan statistic to identify statistically significant dengue clusters. Results were mapped using R. As a second aim, the association between clinical and demographic characteristics and dengue hospitalization was evaluated. Of 3,964 dengue cases reported in Valle del Cauca in 2022, 2,232 (56%) were laboratory-confirmed. Of these, 1,973 occurred in the defined areas of the nine municipalities included in the spatio-temporal analysis of this study. We identified 28 clusters at the sub-municipal level, with radii of 0–0.98 km, lasting 1–6 months and containing 10–114 cases. Twenty-six clusters (92.9%) spanned both warm–dry and cool–wet seasons, and clusters accounted for 32.0% of spatially analyzed cases. 960 patients were hospitalized. Lower socioeconomic status (OR 1.30, 95% CI 1.07–1.57), enrollment in the state-subsidized insurance scheme (OR 1.74, 95% CI 1.41–2.15) compared with the contributory scheme, and age ≥ 70 years compared to ages 20–29 years (OR 2.47, 95% CI 1.51–4.04) were associated with higher odds of hospitalization. Conclusions/Significance: This study identified dengue clusters at the sub-municipal level with the potential to inform reactive dengue control interventions and demonstrated a disproportionate impact on socioeconomically disadvantaged populations and the elderly in Valle del Cauca, Colombia.
- Open Access
- 20 May 2026
- Vol. 82 (5) , e1122-e1125
Crusted, Chronic, and Confusing.
Chronic ulcerative lesions initially treated as bacterial cellulitis were ultimately diagnosed as cutaneous leishmaniasis. This case highlights diagnostic pitfalls in persistent ulcers, the importance of considering endemic exposures, and the role of species identification in guiding therapy.
- 20 May 2026
- Vol. 82 (5) , e1122-e1125
Open AccessCrusted, Chronic, and Confusing.
Chronic ulcerative lesions initially treated as bacterial cellulitis were ultimately diagnosed as cutaneous leishmaniasis. This case highlights diagnostic pitfalls in persistent ulcers, the importance of considering endemic exposures, and the role of species identification in guiding therapy.
- 23 November 2023
- Published by Springer Nature in Current Tropical Medicine Reports
- Vol. 10 (4) , 186-198
Trypanosoma cruzi Central Nervous System Infection—Pathogenesis, Clinical Manifestations, Diagnosis, and Treatment
Purpose of Review Chagas disease (CD) is a neglected tropical disease from the American continent that commonly causes cardiovascular disease. Some patients develop neurological manifestations. We discuss and summarize the pathogenesis, clinical characteristics, diagnosis, and treatment of the central nervous system manifestations of CD. Recent Findings Cerebrospinal fluid quantitative polymerase chain reaction tests and next-generation sequencing in tissue samples have facilitated disease diagnosis and follow-up. Novel presentations, including retinitis, are now reported. A new MRI sign called “Bunch of açai berries appearance”—multiple hypointense nodular lesions—has been described recently. Treatment with benznidazole at higher doses and the role of therapeutic drug monitoring need to be further studied in this setting. Summary A high suspicion index is paramount to diagnosing Chagas’ central nervous system involvement. Standardized molecular diagnostics can aid in the initial workup. Future development of new therapeutic drugs is crucial because of the toxicity profile of the currently available medications.
- 23 November 2023
- Published by Springer Nature in Current Tropical Medicine Reports
- Vol. 10 (4) , 186-198
Trypanosoma cruzi Central Nervous System Infection—Pathogenesis, Clinical Manifestations, Diagnosis, and Treatment
Purpose of Review Chagas disease (CD) is a neglected tropical disease from the American continent that commonly causes cardiovascular disease. Some patients develop neurological manifestations. We discuss and summarize the pathogenesis, clinical characteristics, diagnosis, and treatment of the central nervous system manifestations of CD. Recent Findings Cerebrospinal fluid quantitative polymerase chain reaction tests and next-generation sequencing in tissue samples have facilitated disease diagnosis and follow-up. Novel presentations, including retinitis, are now reported. A new MRI sign called “Bunch of açai berries appearance”—multiple hypointense nodular lesions—has been described recently. Treatment with benznidazole at higher doses and the role of therapeutic drug monitoring need to be further studied in this setting. Summary A high suspicion index is paramount to diagnosing Chagas’ central nervous system involvement. Standardized molecular diagnostics can aid in the initial workup. Future development of new therapeutic drugs is crucial because of the toxicity profile of the currently available medications.
- 6 January 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (1) , e240484
Uncommon pathogens in an immunocompetent host: respiratory isolation of Cunninghamella bertholletiae, Aspergillus niger, Staphylococcus pseudintermedius and adenovirus in a patient with necrotising pneumonia
We present the unusual case of a 60-year-old immunocompetent woman with chronic obstructive pulmonary disease who developed a necrotising pneumonia with isolation of Cunninghamella bertholletiae, Aspergillus niger, Staphylococcus pseudintermedius and adenovirus. The patient recovered with antimicrobial therapy and supportive care in the intensive care unit. The current literature on diagnosis and treatment of these pathogens is reviewed.
- 6 January 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (1) , e240484
Uncommon pathogens in an immunocompetent host: respiratory isolation of Cunninghamella bertholletiae, Aspergillus niger, Staphylococcus pseudintermedius and adenovirus in a patient with necrotising pneumonia
We present the unusual case of a 60-year-old immunocompetent woman with chronic obstructive pulmonary disease who developed a necrotising pneumonia with isolation of Cunninghamella bertholletiae, Aspergillus niger, Staphylococcus pseudintermedius and adenovirus. The patient recovered with antimicrobial therapy and supportive care in the intensive care unit. The current literature on diagnosis and treatment of these pathogens is reviewed.
- Open Access
- 4 December 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S771-S772
1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
Gram negative bacteria (GNB) have been identified as a cause of upper extremity infections and empiric treatment directed to both gram positive and negative organisms is often recommended. Risk-based approaches to establish need for gram-negative coverage may help to minimize unnecessary drug exposure, but further information on such methods are currently lacking. The aim of this study was to identify risk factors associated with the isolation of GNB in patients with upper extremity infections. We reviewed records of patients with upper extremity infections treated in two urban hospitals between March 2018 and July 2020. Prosthetic joint infections were excluded. Baseline demographic, clinical, surgical and microbiology data was collected. Multivariable logistic regression models were screened using Akaike Information Criterion to establish the best model and risk factors associated with isolation of a GNB. We identified 111 patients, the majority of whom were male with frequent history of IV drug use. Deep wound cultures in 30 (33.3%) individuals yielded a GNB, and 80% of these cases were polymicrobial. Among the GNB, most prevalent were Enterobacterales (10.4%), HACEK group (6.39%), and Pseudomonas spp. (4.5%) (Tables 1. and 2.). Infections were mostly limited to the soft tissue structures of the hand and the forearm, with involvements of the joint and bone being second and third most common. The final model identified the use of IV medications (OR 4.14, 95% CI 1.3 - 14.46) together with prior surgery at the site of infection within the last year (OR 5.56, 95% CI 1.06 - 30.98), and having an open wound on presentation (OR 3.03, 95% CI 1.04 - 9.47) as factors independently associated with isolation of a GNB (Table 3). AUROC of 0.702 indicates acceptable model discrimination. Table 1: Baseline characteristics Table 2: Bacterial isolates Table 3: Final model Our logistic regression model identified significant predictors for isolation of GNB in upper extremity infections within this population. Results of this study will assist clinicians in making a better informed decision for the need of empiric gram negative coverage aimed to support the reduction of patient exposure to unnecessary antimicrobial coverage. External validation of the model is warranted prior to application to clinical care. Figure 1: AUROC All Authors: No reported disclosures
- 4 December 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S771-S772
Open Access1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
Gram negative bacteria (GNB) have been identified as a cause of upper extremity infections and empiric treatment directed to both gram positive and negative organisms is often recommended. Risk-based approaches to establish need for gram-negative coverage may help to minimize unnecessary drug exposure, but further information on such methods are currently lacking. The aim of this study was to identify risk factors associated with the isolation of GNB in patients with upper extremity infections. We reviewed records of patients with upper extremity infections treated in two urban hospitals between March 2018 and July 2020. Prosthetic joint infections were excluded. Baseline demographic, clinical, surgical and microbiology data was collected. Multivariable logistic regression models were screened using Akaike Information Criterion to establish the best model and risk factors associated with isolation of a GNB. We identified 111 patients, the majority of whom were male with frequent history of IV drug use. Deep wound cultures in 30 (33.3%) individuals yielded a GNB, and 80% of these cases were polymicrobial. Among the GNB, most prevalent were Enterobacterales (10.4%), HACEK group (6.39%), and Pseudomonas spp. (4.5%) (Tables 1. and 2.). Infections were mostly limited to the soft tissue structures of the hand and the forearm, with involvements of the joint and bone being second and third most common. The final model identified the use of IV medications (OR 4.14, 95% CI 1.3 - 14.46) together with prior surgery at the site of infection within the last year (OR 5.56, 95% CI 1.06 - 30.98), and having an open wound on presentation (OR 3.03, 95% CI 1.04 - 9.47) as factors independently associated with isolation of a GNB (Table 3). AUROC of 0.702 indicates acceptable model discrimination. Table 1: Baseline characteristics Table 2: Bacterial isolates Table 3: Final model Our logistic regression model identified significant predictors for isolation of GNB in upper extremity infections within this population. Results of this study will assist clinicians in making a better informed decision for the need of empiric gram negative coverage aimed to support the reduction of patient exposure to unnecessary antimicrobial coverage. External validation of the model is warranted prior to application to clinical care. Figure 1: AUROC All Authors: No reported disclosures
- Open Access
- 1 November 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S716-S717
1255. External Validation and Systematic Quantification of the Predictive Performance of Carbapenem Resistant Enterobacterales Risk Prediction Models in Hospitalized Patients
Accurately predicting the presence of a carbapenem resistant enterobacterales (CRE) in hospitalized patients presents itself as an opportunity that would support timely initiation of CRE active agents. The aim of this study is to determine how reliably the existing risk prediction models identify patients likely to require empiric anti-CRE treatment, preliminary results of which are presented herein. A systematic search identified all existing CRE prediction models for validation in our patient population. Medical records of hospitalized patients within the Mount Sinai Health System in New York were subsequently reviewed. Data was gathered on model predictors, baseline demographics, clinical information, microbiology results, antibiotic utilization history and index infection. Besides calculating the AUROC, the main outcome of our study was to establish optimal prediction score cutoffs and false positive rates (FPR) where corresponding model performance maintains a false negative rate (FNR) of < 10%, < 20% and < 30%, respectively. 12 models were retained for validation. We identified 106 patients, 41 of which were treated for a CRE infection. Previous admission, organ transplantation, CKD, infection type, and carbapenem use were baseline variables that significantly differed between the groups treated for a CRE or non-CRE related infection (Table 1). The models ability to discriminate varied as evidenced by the AUROC range of 0.5 to 0.77 (Figure 1), suggesting the Seligmen et al. model as the overall best. When evaluated at the pre-specified FNR intervals of < 10%, < 20% and < 30%, the model by Lodise et al., Seligman et al., and Vazquez-Guillamet et al. produced the best FPR, respectively (Table 2). Table 1. Baseline characchteristics Table 2. Model Performance Figure 1. AUROCs Discriminative ability of the risk prediction models showed varying performance. The model by Lodise et al. appears to be most useful when a low risk level is deemed acceptable for failure rate, while at a moderate to high risk of missing a CRE case (20% and 30% FNR), the methods by Seligman and Vazquez-Guillamet et al. are most desirable as they minimize the chance of over-treatment. Additional work to increase sample size and to evaluate the models inter-rater reliability is currently on going. All Authors: No reported disclosures
- 1 November 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S716-S717
Open Access1255. External Validation and Systematic Quantification of the Predictive Performance of Carbapenem Resistant Enterobacterales Risk Prediction Models in Hospitalized Patients
Accurately predicting the presence of a carbapenem resistant enterobacterales (CRE) in hospitalized patients presents itself as an opportunity that would support timely initiation of CRE active agents. The aim of this study is to determine how reliably the existing risk prediction models identify patients likely to require empiric anti-CRE treatment, preliminary results of which are presented herein. A systematic search identified all existing CRE prediction models for validation in our patient population. Medical records of hospitalized patients within the Mount Sinai Health System in New York were subsequently reviewed. Data was gathered on model predictors, baseline demographics, clinical information, microbiology results, antibiotic utilization history and index infection. Besides calculating the AUROC, the main outcome of our study was to establish optimal prediction score cutoffs and false positive rates (FPR) where corresponding model performance maintains a false negative rate (FNR) of < 10%, < 20% and < 30%, respectively. 12 models were retained for validation. We identified 106 patients, 41 of which were treated for a CRE infection. Previous admission, organ transplantation, CKD, infection type, and carbapenem use were baseline variables that significantly differed between the groups treated for a CRE or non-CRE related infection (Table 1). The models ability to discriminate varied as evidenced by the AUROC range of 0.5 to 0.77 (Figure 1), suggesting the Seligmen et al. model as the overall best. When evaluated at the pre-specified FNR intervals of < 10%, < 20% and < 30%, the model by Lodise et al., Seligman et al., and Vazquez-Guillamet et al. produced the best FPR, respectively (Table 2). Table 1. Baseline characchteristics Table 2. Model Performance Figure 1. AUROCs Discriminative ability of the risk prediction models showed varying performance. The model by Lodise et al. appears to be most useful when a low risk level is deemed acceptable for failure rate, while at a moderate to high risk of missing a CRE case (20% and 30% FNR), the methods by Seligman and Vazquez-Guillamet et al. are most desirable as they minimize the chance of over-treatment. Additional work to increase sample size and to evaluate the models inter-rater reliability is currently on going. All Authors: No reported disclosures